STEVEN I SHERMAN to Magnetic Resonance Imaging
This is a "connection" page, showing publications STEVEN I SHERMAN has written about Magnetic Resonance Imaging.
Connection Strength
0.043
-
A phase I study of cabozantinib (XL184) in patients with differentiated thyroid cancer. Thyroid. 2014 Oct; 24(10):1508-14.
Score: 0.037
-
Mosaicism in von Hippel-Lindau disease: an event important to recognize. J Cell Mol Med. 2007 Nov-Dec; 11(6):1408-15.
Score: 0.006